218 related articles for article (PubMed ID: 29601948)
1. Microarray analysis of obese women with polycystic ovary syndrome for key gene screening, key pathway identification and drug prediction.
Wei L; Xin C; Wang W; Hao C
Gene; 2018 Jun; 661():85-94. PubMed ID: 29601948
[TBL] [Abstract][Full Text] [Related]
2. Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients.
Kenigsberg S; Bentov Y; Chalifa-Caspi V; Potashnik G; Ofir R; Birk OS
Mol Hum Reprod; 2009 Feb; 15(2):89-103. PubMed ID: 19141487
[TBL] [Abstract][Full Text] [Related]
3. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
[TBL] [Abstract][Full Text] [Related]
4. Identification of the key pathways and genes related to polycystic ovary syndrome using bioinformatics analysis.
Bi X; Zhai Z; Wang S
Gen Physiol Biophys; 2019 May; 38(3):205-214. PubMed ID: 31184307
[TBL] [Abstract][Full Text] [Related]
5. Pathway and network-based analysis of genome-wide association studies and RT-PCR validation in polycystic ovary syndrome.
Shen H; Liang Z; Zheng S; Li X
Int J Mol Med; 2017 Nov; 40(5):1385-1396. PubMed ID: 28949383
[TBL] [Abstract][Full Text] [Related]
6. Several critical genes and microRNAs associated with the development of polycystic ovary syndrome.
Wang W; Ji J; Li J; Ren Q; Gu J; Zhao Y; Hong D; Guo Q; Tan Y
Ann Endocrinol (Paris); 2020 Feb; 81(1):18-27. PubMed ID: 32127169
[TBL] [Abstract][Full Text] [Related]
7. The peripheral blood transcriptome identifies dysregulation of inflammatory response genes in polycystic ovary syndrome.
Su NJ; Ma J; Feng DF; Zhou S; Li ZT; Zhou WP; Deng H; Liang JY; Yang XH; Zhang YM; Liu FH; Zhang L
Gynecol Endocrinol; 2018 Jul; 34(7):584-588. PubMed ID: 29262729
[TBL] [Abstract][Full Text] [Related]
8. Characterization of microRNA profile in human cumulus granulosa cells: Identification of microRNAs that regulate Notch signaling and are associated with PCOS.
Xu B; Zhang YW; Tong XH; Liu YS
Mol Cell Endocrinol; 2015 Mar; 404():26-36. PubMed ID: 25622783
[TBL] [Abstract][Full Text] [Related]
9. Non-targeted profiling of circulating microRNAs in women with polycystic ovary syndrome (PCOS): effects of obesity and sex hormones.
Murri M; Insenser M; Fernández-Durán E; San-Millán JL; Luque-Ramírez M; Escobar-Morreale HF
Metabolism; 2018 Sep; 86():49-60. PubMed ID: 29410349
[TBL] [Abstract][Full Text] [Related]
10. Functional microarray analysis of differentially expressed genes in granulosa cells from women with polycystic ovary syndrome related to MAPK/ERK signaling.
Lan CW; Chen MJ; Tai KY; Yu DC; Yang YC; Jan PS; Yang YS; Chen HF; Ho HN
Sci Rep; 2015 Oct; 5():14994. PubMed ID: 26459919
[TBL] [Abstract][Full Text] [Related]
11. Identification of key genes and miRNAs related to polycystic ovary syndrome by comprehensive analysis of microarray.
Sun Z; Wang Y; Wei T; Liu L
BMC Med Genomics; 2022 Dec; 15(1):267. PubMed ID: 36544152
[TBL] [Abstract][Full Text] [Related]
12. Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome.
Ding L; Gao F; Zhang M; Yan W; Tang R; Zhang C; Chen ZJ
Fertil Steril; 2016 May; 105(5):1330-1337.e3. PubMed ID: 26868993
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profiling.
Romero-Ruiz A; Pineda B; Ovelleiro D; Perdices-Lopez C; Torres E; Vazquez MJ; Guler I; Jiménez Á; Pineda R; Persano M; Romero-Baldonado C; Arjona JE; Lorente J; Muñoz C; Paz E; Garcia-Maceira FI; Arjona-Sánchez Á; Tena-Sempere M
Eur J Endocrinol; 2021 Oct; 185(5):637-652. PubMed ID: 34403358
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics-based analysis of potential therapeutic target genes for polycystic ovary syndrome.
Liu Y; Yu J; Li J; Li W; Ma H
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):169-175. PubMed ID: 38678611
[TBL] [Abstract][Full Text] [Related]
15. Characterization of circular RNA expression profiles in cumulus cells from patients with polycystic ovary syndrome.
Che Q; Liu M; Xu J; Liu Y; Cao X; Dong X; Liu S
Fertil Steril; 2019 Jun; 111(6):1243-1251.e1. PubMed ID: 30979425
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of long noncoding RNAs in cumulus cells isolated from PCOS patients.
Huang X; Hao C; Bao H; Wang M; Dai H
J Assist Reprod Genet; 2016 Jan; 33(1):111-21. PubMed ID: 26650608
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor‑microRNA synergistic regulatory network revealing the mechanism of polycystic ovary syndrome.
Liu HY; Huang YL; Liu JQ; Huang Q
Mol Med Rep; 2016 May; 13(5):3920-8. PubMed ID: 27035648
[TBL] [Abstract][Full Text] [Related]
18. Identification of Hub Genes and Biomarkers between Hyperandrogen and Normoandrogen Polycystic Ovary Syndrome by Bioinformatics Analysis.
Zhang T; Liu Y; Li X; Hu B
Comb Chem High Throughput Screen; 2023; 26(1):126-134. PubMed ID: 35379124
[TBL] [Abstract][Full Text] [Related]
19. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
[TBL] [Abstract][Full Text] [Related]
20. Association between genes encoding components of the Leutinizing hormone/Luteinizing hormone-choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women.
El-Shal AS; Zidan HE; Rashad NM; Abdelaziz AM; Harira MM
IUBMB Life; 2016 Jan; 68(1):23-36. PubMed ID: 26662070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
